Skip to main content
. 2020 Oct 30;21(21):8133. doi: 10.3390/ijms21218133

Table 1.

Overview of the most relevant studies investigating potential associations between viruses and cancers of the digestive system.

First Author Year Virus Cancer Type Sample Origin Number of Samples Observation Ref.
Maden 1992 HPV Oral USA 131 HPV-6 is associated with oral cancer [36]
Jalouli 2012 HPV, HSV, EBV Oral UK, Sweden, Sudan, Norway, USA, Yemen, India, Sri Lanka 155 Higher proportion of samples with HSV and EBV in industrialized countries [37]
Bjørge 1997 HPV Esophageal Norway 228 Increased risk of developing cancer among HPV-16-seropositive subjects [38]
Zhang 2015 HPV Esophageal China 3044 HPV-16 is a possible risk factor [39]
Wang 2010 HPV Esophageal China, USA 435 HPV infection is common in esophageal carcinoma, independent of region and ethnic group of origin [40]
Kirgan 1990 HPV Colorectal USA 90 Association between HPV and colon neoplasia [41]
Lee 2001 HPV Colorectal Taiwan 38 HPV-18 is a possible risk factor [42]
Alexandrou 2014 HPV Anal Greece 11 Lower incidence of HPV in anal cancer compared to other Western countries [43]
Kabarriti 2019 HPV Anal USA 5927 HPV is a significant prognostic marker in anal cancer, especially for locally advanced disease [44]
Muresu 2020 HPV Anal Italy 30 HPV is a possible risk factor [45]
Awerkiew 2003 HPV, EBV Esophageal Germany 37 EBV, but not HPV, was detected in esophageal cancer samples [46]
Martínez-López 2014 EBV Gastric Mexico 297 Possible role for EBV in gastric cancer and early precursor lesions. [47]
Corallo 2020 EBV Gastric Italy 175 Patients with EBV-positive gastric cancer who did not receive ICI had a better response to first-line chemotherapy and better survival compared with EBV-negative patients [48]
Li 2004 EBV Hepatic China 141 Presence of HBV infection in HCC tissues [49]
Song 2006 EBV Colorectal China 115 Possible association of EBV with colorectal carcinoma [50]
Fiorina 2014 HPV, EBV, JCV, BKV Colorectal Italy 44 No or weak association of HPV, EBV, JCV, and BKV with colorectal cancer [51]
Laghi 1999 JCV Colorectal USA 23 JCV DNA may play a role in the chromosomal instability observed in colorectal carcinogenesis [52]
Hori 2005 JCV Colorectal Japan 64 Possible role of JCV in colorectal carcinogenesis [53]
Jung 2008 JCV Colorectal USA 74 JCV T-Antigen is expressed in the early stage of colorectal cancer [54]
Tokita 2002 TTV Hepatic Japan 237 High TTV abundance is an independent risk factor [55]
Iloeje 2010 HBV Pancreatic Taiwan 22,471 Chronic HBV infection may be associated with an increased risk of pancreatic cancer [56]
Zhou 2012 HBV, HCV Bile duct Meta-analyses
(13 case-control studies and 3 cohort studies)
- HBV and HCV are risk factors in bile duct cancer [57]
Hassan 2008 HBV Pancreatic USA 476 Past exposure to HBV is a possible risk factor in pancreatic cancer [58]
Su 2020 HBV Colorectal Taiwan 69,478 Chronic HBV infection is strongly associated with increased risk of developing colorectal cancer [59]
Dimberg 2013 CMV Colorectal Sweden, Vietnam 202 CMV DNA rate was significantly higher in cancerous tissues compared to normal tissues [60]
Chen 2016 CMV Colorectal Taiwan 556 More favorable disease-free survival rate in non-elderly patients with CMV-positive tumors, specifically in patients with stage III disease [61]
Chen 2015 CMV Colorectal USA, France, Italy, Japan, China, Taiwan 92 Specific genetic CMV polymorphisms are associated with different clinical outcomes [62]
Jin 2019 HIV Anal Australia Not applicable People living with HIV are at markedly higher risk of anal cancer [63]
Colón-López 2018 HIV Anal USA Not applicable Anal cancer incidence is markedly elevated among people with HIV infection [64]
Grew 2015 HIV Anal USA Not applicable HIV-positive patients had significantly worse overall and colostomy-free survival rates than HIV-negative patients [65]

Abbreviations: HPV: human papillomavirus; HSV: herpes simplex virus; EBV: Epstein–Barr virus; ICI: immune-checkpoint inhibitor; HCC: hepatocellular carcinoma; JCV: John Cunningham virus; BKV: BK virus; TTV: TT virus; HBV: hepatitis B virus; HCV: hepatitis C virus; CMV: cytomegalovirus; HIV: human immunodeficiency virus. Not applicable means that the study did not involve human specimens.